656
Views
119
CrossRef citations to date
0
Altmetric
Research Article

Critical Observations on the Neurotoxicity of Silver

Pages 237-250 | Published online: 10 Oct 2008

REFERENCES

  • Wan A. T., Conyers RAJ., Coombs C. J., Masterton J. P. Determination of silver in blood, urine and tissues of volunteers and burn patients. Clin. Chem. 1991; 37: 1683
  • Lansdown A. B.G. Physiological and toxicological changes in the skin resulting from the action and interaction of metal ions. CRC Crit. Rev. Toxicol. 1995; 25: 397
  • Lansdown A. B.G. Silver 2: Toxicity in mammals and how its products aid wound repair. J. Wound Care 2002; 11: 173
  • White R. J. A historical review of silver in wound management. Br. J. Nurs. 1999; S3–S8
  • Klasen H. J. A historical review of the history of silver in burns. Burns 2000; 26: 117
  • Hambidge A. Reviewing efficacy of alternative water treatment techniques. Health Estate 2001; 55: 23
  • Lansdown A. B.G., Williams A., Chandler S., Benfield S. Silver absorption and antibacterial efficacy of silver dressings. J. Wound Care 2005; 14/4: 155
  • Humphreys S. D.M., Routledge P. A. The toxicology of silver nitrate. Adverse Drug React. Toxicol. Rev. 1998; 17: 115
  • Fung M. C., Bowen D. L. Silver products for medical indications: risk-benefit assessment. Clin. Toxicol. 1996; 34: 119
  • Boosalis M. G., McCall J.T., Ahrenholtz D. H., et al. Serum and urinary silver levels in thermal injury patients. Surgery 1982; 101: 40
  • Pariser R. J. Generalised argyria: clinicopathologic features and histochemical studies. Arch. Dermatol. 1978; 114: 373
  • Coombs C. J., Wan A. T., Masterton J. P., et al. Do burn patients have a silver lining?. Burns 1992; 18: 179
  • Lansdown A. B.G., Williams A. How safe is silver in wound care?. J. Wound Care 2004; 13: 131
  • Bleehan S. S., Gold D. J., Harrington C. I., et al. Occupational argyria: Light and electron microscopic studies and X-ray microanalysis. Br. J. Dermatol. 1981; 104: 19
  • Deitl H. W., Anzil A. P., Mehraein P. Brain involvement in generalised argyria. Clin. Neuropathol. 1984; 3: 32
  • Landas S., Bonsib S. M., Ellerbroek R., Fischer J. Argyria: Microanalytic-morphologic correlation using paraffin embedded tissue. Ultrastruct. Pathol. 1986; 10: 129
  • Mirsattari S. M., Hammond A. R., Sharpe M. D., et al. Myoclonic status epilepticus following repeated injection of colloidal silver. Neurology 2004; 62: 1408
  • Vik H., Andersen K. J., Juhlshamn K., Todnem K. Neuropathy caused by silver absorption from arthroplasty cement. Lancet 1985; I: 872
  • Sudmann E., Vik H., Rait M., et al. Systemic and local silver accumulation after total hip replacement using silver-impregnated bone cement. Med. Prog. Technol. 1994; 20: 179–184
  • Roper W. L. Toxicological profile for silver. 1990, Agency for Toxic Substances and Disease Registry, U.S. Public Health Service, Atlanta, GA.
  • Danscher G., Rungby J. Differentiation of histochemically visualised mercury and silver. Histochemistry 1986; 18: 109
  • Stoltenberg M., Juhl S., Poulsen E. H., Ernst E. Autometallographic detection of silver in hypothalamic neurons in rats exposed to silver nitrate. J. Appl. Toxicol. 1994; 14: 275
  • Lansdown A. B.G. Silver in health care: antmicrobial effects and safety in use. Curr. Prob. Dermatol. 2006; 33: 17
  • Ovington L. G. Nanocrystalline silver: where the old and familiar meets a new frontier. Wounds 2001; 13: 5
  • Burrell R. E. A scientific perspective on the use of topical silver preparations. Ostomy Wound Manage. 2003; 49: 19
  • Tredgett E. E., Shankowski H. A., Groenveld A., Burrell R. E. A matched pair, randomised study evaluating the efficacy and safety of Acticoat® silver coated dressing for the treatment of burn wounds. J. Burn Care Rehab. 1998; 19: 531
  • Fonnier F. Neurotoxicology. General and Applied Toxicology, B. Ballantyne, T. Marrs., T. Sylversen. MacMillan Reference Ltd., London 1999; 631, Vol. 2
  • LeFauconnier J. M., Bouchard C. Neurotoxicology. General and Applied Toxicology, B Ballantyne, T Marrs, P Turner. MacMillan Press, London 1993; 469, Vol. 1
  • Zheng W., Aschner M., Ghersi-Egea, J.-F. Brain barrier systems: A new frontier in metal neurotoxicological research. Toxicol. Appl. Pharmacol. 2003; 192: 1
  • Hirano A., Levine S., Zimmerman H. M. Experimental cyanide encephalopathy: Electron microscopic observation of early lesions in white matter. J. Neuropathol. Exp. Neurol. 1967; 26: 200
  • Hirano A. Edema damage. Neurosci. Res. Prog. Bull. 1967; 9: 493
  • Webster H., de F., Ulsamer A. G., O'Connell M.F. Hexachlorophene induced myelin lesions in developing nervous system of Xenopustadpoles: Morphological and biochemical observations. J. Neuropathol. Exp. Neurol. 1974; 33: 144
  • Zheng W. Toxicology of the choroid plexus: Special reference to metal-induced toxicities. Microsc. Res. Tech. 2001; 52: 89
  • Rappoport S. I. The Blood Brain Barrier in Physiology and Medicine. Raven Press, New York 1976
  • Davson H. The Physiology of the Cerebrospinal Fluid. Churchill, London
  • Bouchaud C., Le Bert M., Dupouey P. Are close contacts between astrocytes and endothelial cells a prerequisite condition of a blood-brain barrier? The rat sub-fornical organ as an example. Biol. Cell. 1967; 67: 159
  • Goldman E. E. Die aussere und innere Sekretion des gesunden und kranken organismus im Lichte der vitalen Färbung. Bewitr. Z. Klin. Chir. 1909; 64: 192–265
  • Goldman E. E. Vitalfärbung am Zentralnervensystem. Beitrag zur Physiologie des Plexus Choroideus und der Hirnhaute (Berlin). 1913
  • Millen J. W., Woolham D. M.H. Anatomy of the Cerebrospinal Fluid. Oxford University Press, U.K. 1962
  • Wright E. M. Mechanisms of ion transport across the choroid plexus. J. Physiol. 1972; 226: 54
  • Cserr H. F. Physiology of the choroid plexus. Physiol. Rev. 1971; 51: 273
  • Freidheim E., Corvi C., Graziano J., et al. Choroid plexus as a protective sink for heavy metals. Lancet 1983; I(182)981
  • Takeuchi E., Eto K., Tokunaga H. Mercury level and histochemical distribution in the human brain with Minamata disease following a long term clinical course of 26 years. Neurotoxicology 1989; 10: 651
  • Manton W. I., Kirkpatrick J. B., Cook J. D. Does the choroid plexus really protect the brain from lead?. Lancet 1984; ii: 351
  • Danscher G. Light and electron microscopic localisation of silver in biological tissue. Histochemistry 1981; 71: 177
  • Rungby J., Danscher G. Localisation of exogenous silver in brain and spinal cord of silver-exposed rats. Acta Neuropathol (Berlin) 1983; 60: 92
  • Danscher G., Stoltenberg M., Juhl S. How to detect gold silver and mercury in human brain and other tissues by autometallographic silver amplification. Neuropathol Appl. Neurobiol. 1994; 20: 454
  • Stoltenberg M., Danscher G. Histochemical differentiation of autometallographically traceable metals (Au, Ag, Hg, Bi, Zn): Protocols for chemical removal of separate autometallographic metal clusters on Epon sections. Histochem. J. 2000; 32: 545
  • Scott W. L. Silver uptake in the brains of chronically gamma-irradiated rats: A study of neutron activation analysis. Radiat. Res. 1967; 31: 522
  • Dempsey E. W., Wistlocki G. B. An electron microscopic study of the blood brain barrier in the rat employing silver nitrate as a vital stain. J. Biophys. Biochem. Cytol. 1955; 1: 245
  • Van Breemen V.L., Clemente C. D. Silver deposition in the central nervous system and the haemoencephalic barrier studies with the electron microscope. J. Biophys. Biochem. Cytol. 1955; 1: 161
  • Scott K. G., Hamilton J. G. The metabolism of silver in the rat with radio-silver used as an indicator. Univ. Calif. Publ. Pharmacol 1950; 2: 241
  • Furchner J. E., Richmond C. R., Drake G. A. Comparative metabolism of radionuclides in mammals. IV. Retention of silver-111n in the mouse, rat, monkey and dog. Health Phys. 1968; 15: 505
  • Wistlocki G. B., Leduc E. H. Vital staining of the haemoencephalic barrier by silver nitrate and trypan blue, and cytological comparisons of the neurohypophysis, pineal body, area postrema, intercolumnar tubercle and supra-optic crest. J. Comp. Neurol. 1952; 96: 371
  • Scott T., Norman P. M. Silver deposition in arteriolar basal laminae in the cerebral cortex of argyric rats. Acta Neuropathol. 1980; 52: 243
  • Walker F. Basement membrane turnover in man. J. Pathol. 1972; 107: 123
  • Kharchenko P. D., Berdyshew G. D., Stepaneko P. Z., Velikoivanenko A. A. Change in nucleic acid level in rat brain and liver during long term introduction of silver ions in drinking water. Fiziol. Zh. (Kiev) 1973; 19: 362
  • Barkov G. D., El Piner L.I. The need for limiting the silver content of drinking water. Gigiena Sanit. 1968; 33: 16
  • Rungby J., Danscher G. Neuronal accumulation of silver in brains of progeny from argyric rats. Acta Neuropathol. (Berlin) 1983; 61: 258
  • Rungby J. Experimental argyrosis: ultrastructural localisation of silver in rat eye. Exp. Mol. Pathol. 1986; 45: 22
  • Rungby J., Slomianka L., Danscher G., et al. A quantitative evaluation of the neurotoxic effect of silver on the volumes of the components of the developing rat hippocampus. Toxicology 1987; 43: 261
  • Rungby J. An experimental study of silver in the nervous system and aspects of its general cellular toxicity. Dan. Med. Bull. 1990; 37: 442
  • Thorlacius-Ussing O., Rungby J. Ultrastructural localisation of exogenous silver in the anterior pituitary gland of the rat. Exp. Mol. Pathol. 1984; 41: 58
  • Rungby J. Exogenous silver in dorsal root ganglia, peripheral nerve, enteric ganglia and adrenal medulla. Acta Neuropathol. (Berlin) 1986; 69: 45
  • Reinhardt G., Geldmacher V., Mallinkrodt M., et al. Akute tödliche Vergiftug mit Silbernitrat als Folge eines Abreibungs versuches. Arch. Kriminol. 1971; 148: 69
  • Rungby J., Danscher G. Hypoactivity in silver exposed mice. Acta Pharmacol. Toxicol. (Copen.) 1984; 55: 398
  • Pelkonen K. H.O., Heinonen-Tanski H., Hänninen O. O.P. Accumulation of silver from drinking water into cerebellum and musculus soleus in mice. Toxicology 2003; 186: 151
  • Wachter B. G., Leonetti J. P., Lee J. M., et al. Silver nitrate injury in the rat sciatic nerve: A model of facial nerve injury. Otolaryngol. Head Neck Surg. 2002; 127: 48
  • Hachem R. Y., Wright K. C., Zermeno A., et al. Evaluation of the silver iontophoretic catheter in an animal model. Biomaterials 2003; 24: 3619
  • Wang X., Wang N. Z., Zhang O. Z., et al. Tissue determination of silver following topical use of silver sulphadiazine in extensive burns. Burns 1985; 11: 197
  • DiVincenzo G. D., Giordiana C. J., Schreiver L. S. Biologic monitoring of workers exposed to silver. Int. Arch. Occup. Environ. Health 1985; 56: 207
  • Boosalis M. G., McCall J.T., Ahrenholz D. H., et al. Serum and urinary silver levels in thermally injured patients. Surgery 1987; 101: 40
  • Sano S., Fujimori R., Takashima M., Itokawa Y. Absorption, excretion and tissue distribution of silver sulphadiazine. Burns 1981; 8: 278
  • Patty's Industrial Hygiene and Toxicology 3rd, GD Clayton, FE Clayton. John Wiley, New York 1981; 1881, Vol. 2A
  • Polachek A. A., Cope C. B., Williard R. F., Enns T. Metabolism of radioactive silver in a patient with carcinoid. J. Lab. Clin. Med. 1960; 56: 499
  • Buckley W. R., Terhaar C. J. The skin as an excretory organ in argyria. Trans. St. John's Dermatol. Soc. 1973; 59: 39
  • Suzuki H., Baba S., Uchigashi S., Murase M. Localised argyria with chrysiasis caused by implanted acupuncture needles. Distribution and chemical forms of silver and gold in cutaneous tissue by electron microscopy and X-ray microanalysis. J. Am. Acad. Dermatol. 1993; 29: 833
  • Sato S., Sueki H., Nishijima A. Two unusual cases of argyria: the application of an improved tissue processing method for X-ray microanalysis of selenium and sulphur. Br. J. Dermatol. 1999; 140: 158
  • Gettler A. O., Rhoads C. P., Weiss A. A contribution to the pathology of generalised argyria with a discussion on the fate of silver in the human body. Am. J. Pathol. 1927; 3: 631
  • Moss A., Sugar A., Hargett N. A., et al. The ocular manifestations and functional effects of occupational argyrosis. Arch. Ophthalmol. 1979; 97: 906
  • Rosenman K. D., Moss A., Kon S. Argyria: Clinical implications of exposure to silver nitrate and silver oxide. J. Occup. Med. 1979; 21: 430
  • Schlotzer-Schrehardt U., Holbach L. M., Hofmann-Rummelt C., Naumann G. O. Multifocal corneal argyrosis after explosion injury. Cornea 2001; 20: 553
  • Sollemann T. A Manual of Pharmacology 6th. Saunders, Philadelphia 1942
  • Lansdown A. B.G. Controversies over colloidal silver. J. Wound Care 2003; 12: 120
  • Consumer Advisory Bulletin. National Center for Complementary and Alternative Medicine. 2004, Colloidal silver products. Web site: nccam.nih.gov.
  • Marshall J. P., Schneider R. P. Systemic argyria secondary to topical silver nitrate. Arch. Dermatol. 1977; 113: 1077
  • Timmins A. C., Morgan A. R. Argyria or cyanosis?. Anaesthesia 1988; 43: 755
  • Tomi N. S., Kränke B., Aberfer W. A silver man. Lancet 2004; 363: 532
  • Goebel H. H., Muller J. Ultrastructural observations on silver deposition in the choroid plexus of a patient with argyria. Acta Neuropathol. (Berlin) 1973; 26: 247
  • Landas S., Fischer J., Wilkin L. D., et al. Demonstration of regional blood brain barrier permeability in the human brain. Neurosci. Lett. 1985; 57: 251
  • Steininger H., Langer E., Stommer P. Generalised argyrosis. Dtsch. Med. Woschenschr. 1990; 115: 657
  • Westhofen M., Schafer H. Generalised argyria in man: Neurological, ultrastructural and X-ray microanalytical findings. Arch. Otorhinolaryngol. 1986; 243: 260
  • Lansdown A. B.G., Mirastschijiski U., Stubbs N., Scanlon E., Ågren M.S. Zinc in wound healing: theoretical, experimental and clinical aspects. Wound Rep. Regen. 2006; 15: 2–16
  • Bray Health and Leisure. Toughened silver nitrate caustics in medicine. 1997, warts, verrucae, cautery, granuloma. http://www.bray.co.uk/notes01.htm
  • Bader K. F. Organ deposition of silver following silver nitrate therapy. Plast. Reconstr. Surg. 1967; 37: 550
  • Lowe D. G., Levison D. A., Crocker P. R., Shepherd J. H. Silver deposition in the cervix following application of silver nitrate as a cauterizing agent. J. Clin. Pathol. 1988; 41: 871
  • Dollery C. Silver sulphadiazine. Therapeutic Drugs 1991, Elsevier, Amsterdam
  • Cook D. S. Crystal and molecular structure of silver sulphadiazine (N1-pyrimidin-2-ylsulphanilamide). J. Chem. Soc. Perkin Trans. 1975; II: 1021
  • White R. J., Cooper R. Silver sulphadiazine: A review of the evidence. Wounds UK 2005; 2: 51
  • Baxter C. R. Topical use of 1% silver sulphadiazine. Contemporary Burn Management, HC Polk, HH Stone. Little Brown, Boston 1971; 217
  • Iwasaki S., Yoshimura A., Ideura T., et al. Elimination study of silver in a haemodyalised burn patient treated with silver sulphadiazine cream. Am. J. Kidney Dis. 1997; 30: 287
  • Lansdown A. B.G., Myers S. R., Clarke J., O'Sullivan P. A re-appraisal of the role of cerium in burn wound management. J. Wound Care 2003; 12: 113
  • Lansdown A. B.G. A review of the use of silver in wound care: Facts and fallacies. Br. J. Nurs. Tissue Viability Suppl. 2004; 13: S6
  • Lansdown A. B.G. Silver in wound care and management. 2003, Wound Care Society; Educational Suppl
  • Lansdown A. B.G. Silver in healthcare: Antimicrobial effects and safety in use. Curr. Probl. Dermatol. 2006; 33: 17
  • Maki D. G., Tambyah P. A. Engineering out the risk of infection with urinary catheters. Emerg. Infect. Dis. 2001; 7: 342
  • Elliott T. S.J. Role of antimicrobial central venous catheters for prevention of associated infections. J. Antimicrobial Chemother. 1999; 43: 441
  • Saint S., Savel R. H., Mathay M. A. Enhancing safety of critically ill patients by reducing urinary and central venous catheter-related infections. Am. J. Respir. Crit. Care Med. 2002; 165: 1475
  • Thibon P., Le Coutour X., Leroyer R., Fabry J. Randomised multi-centre trial of the effect of a catheter coted with hydrogel and silver salts on the incidence of hospital acquired infections. J. Hosp. Infect. 1999; 45: 117
  • Sammuel U., Guggenbichler J. P. Prevention of catheter-related infections: The potential of a new nano-silver impregnated catheter. Int. J. Antimicrob. Agents 2004; 23(Suppl 1)S75
  • Guggenbichler J.P., Böswald M., Lugauer S., Krall T. A new technology of micro-dispersed silver in polyurethane induces antimicrobial activity in central venous catheters. Infection 1999; 27(suppl 1)S16
  • Joyce-Wöhrmann R. J., Münstedt H. Determination of the silver ion release from polyurethanes enriched with silver. Infection 1999; 27(Suppl 1)S46
  • Brosnahan J., Jull A., Tracy C. Types of urethral catheters for management of short-term problems in hospitalised adults. Cochrane Database Syst Rev. 2004; 1, CD004013
  • Cymet T. Do silver alloy catheters increase the risk of systemic argyria?. Arch. Int. Med. 2001; 161: 1014
  • Liakhovitaskii N. S. Argyria of the urethra. Urol. Nefrol. (Moscow) 1968; 33: 59
  • Saint S., Veenstra D. L., Sullivan S. D., et al. The potential clinical and economic benefits of silver alloy urinary catheters in preventing urinary tract infection. Arch. Int. Med. 2000; 160: 2670
  • Tobin E. J., Bambauer R. Silver coating of dialysis catheters to reduce bacterial colonisation and infection. Ther. Apheresis Dial. 2003; 7: 504
  • Maki D. G., Stolz S. M., Wheeler S., Mermel L. A. Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter. A randomised controlled trial. Ann Int Med. 1997; 127: 257
  • Medicines and Healthcare Products Regulatory Agency (UK). AN 1999(06) Thromboembolytic complications involving Silzone mechanical heart valve. 2005, http://www.medical-devices.gov.uk/mda/mdawebsitev2.nsf/0/148CDBACE98226AB
  • Langanki D., Ogle M., Cameron J. D., et al. Evaluation of a novel bioprosthetic heart valve incorporating anti-calcification and antimicrobial technology in a sheep model. J. Heart Valve Dis. 1998; 7: 633
  • Tanita Y., Kato T., Hanada K., Tagami H. Blue macules and localised argyria caused by implanted acupuncture needles. Electron microscopy and roentgenographic microanalysis of deposited metal. Arch. Dermatol. 1985; 121: 1550
  • Rosenblatt M. J., Cymet T. C. Argyria: Report of a case associated with abnormal encephalographic and brain scan findings. J. Am. Osteopath. Assoc. 1987; 87: 509
  • East B. W., Boddy K., Williams E. D., et al. Silver retention, total body silver and tissue silver concentrations in argyria associated with exposure to an anti-smoking remedy containing silver acetate. Clin. Exp. Dermatol. 1980; 5: 305
  • Bielchowsky M. J. Psychol. Neurol. (Leipzig) 1904; 3: 169
  • Bielchowsy M. J. Psychol. Neurol. (Leipzig) 1909; 12: 135
  • Gilmore J. P., Fozzard H. A. Liver function following thermal injury. Am. J. Physiol. 1960; 199: 491
  • Konigova R., Dolinayova I. Biochemical changes in burn liver. Acta Chir. Plast. 1980; 22: 171
  • Bremner I., Beattie J. H. Metallothioneins and trace minerals. Ann. Rev. Nutr. 1990; 10: 63
  • Simpkins C. O. Metallothoiloneins and human disease. Cell Mol. Biol. 2000; 46: 465
  • Lansdown A. B.G., Sampson B., Rowe A. M. Metallothionein: Implications in wound healing. Wound Rep. Regen. 1999; 8: A306
  • Lansdown A. B.G. Metallothioneins: potential therapeutic aids for wound healing in the skin. Wound Rep. Regen. 2002; 10: 130
  • Molinero A., Carrasco J., Hernandez J., Hildago J. Effect of nitric oxide synthesis inhibition on mouse liver and brain metallothionein expression. Neurochem. Int. 1998; 33: 559
  • Aschner M. The functional significance of brain metallothionein. Fed. Assoc. Soc, Exp, Biol. 1996; 10: 1129
  • Ceballos D., Lago N., Verdú E., et al. Role of metallothioneins in peripheral nerve function and regeneration. Cell Mol. Life Sci. 2003; 60: 1209
  • Drake P. L., Hazelwood K. J. Exposure related health effects of silver and silver compounds: A review. Ann. Occup. Hyg. 2005; 49: 575
  • American Congress of Government Industrial Hygienists (ACGIH). Documentation of threshold limit values and biological exposure indices. 2001, Supplement to the 6th ed

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.